参考文献/References:
[1] Buti M,Tsai N,Petersen J,et al.Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virusinfection[J].Digestive Diseases and Sciences,2015,60(5):1457-1464.
[2] Schweitzer A,Horn J,Mikolajczyk RT,et al.Estimations of worldwide prevalence of chronic hepatitis B virus infection:a systematic review of data published between 1965 and 2013[J].The Lancet,2015,386(10003):1546-1555.
[3] 黄明清,胡 丽,咸建春.慢性乙型肝炎病毒感染患者表面抗原定量检测与病毒载量的相关性[J].中华医院感染学杂志,2013,23(14):3314-3316.
Huang MQ,Hu L,Xian JC.Relationship between detection of surface antigen quantity at different phases and viral load of patients with chronic hepatitis B virus infection[J].China J Nosocomio,2013,23(14):3314-3316.
[4] Denniston MM,Jiles RB,Drobeniuc J,et al.Chronic hepatitis C virus infection in the United States,national health and nutrition examination survey 2003 to 2010[J].Annals of Internal Medicine,2014,160(5):293-300.
[5] 孔媛媛,尤 红,贾继东,等.世界卫生组织《慢性乙型肝炎病毒感染预防、关怀和治疗指南》制定方法学和核心建议点评[J].中华肝脏病杂志,2015,23(7):485-487.
Kong YY,You H,Jia JD,et al.Commentary on key recommendations andguidelines development methodology of world health organization guidelines forprevention,care and treatment of persons with chronic Hepatitis B infection[J].The Chinese Journal of Hepatology,22015,23(7):485-487.
[6] Gordon SC,Lamerato LE,Rupp LB,et al.Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population[J].Clinical Gastroenterology and Hepatology,2014,12(5):885-893.
[7] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].中华传染病杂志,2011,29(2):65-80.
Chinese Society of Hepatology and Chinese Society Infectious Diseases Chinese Medical Association.The guidelines of prevention and treatment for chronic hepatitis B(2010 Version)[J].Chinese Journal of Infectious Diseases,2011,29(2):65-80.
[8] Rehermann B,Bertoletti A.Immunological aspects of antiviral therapy ofchronic hepatitis B virus and hepatitis C virus infections[J].Hepatology,2015,61(2):712-721.
[9] Trépo C,Chan HL,Lok A.Hepatitis B virus infection[J].The Lancet,2014,384(9959):2053-2063.
[10] 周红星,江应安.乙型肝炎病毒表面抗原在慢性乙型肝炎病毒感染后不同临床阶段的定量检测及临床意义[J].中国医师进修杂志,2014,37(24):15-18.
Zhou HX,Jiang YA.Hepatitis B virus surface antigen quantitative value in different stages of chronic hepatitis B virus infection[J].Chinese Journal of Postgraduates of Medicine,2014,37(24):15-18.
[11] 周洪波,李晶媛,赵勇华,等.乙型肝炎病毒感染不同阶段HBsAg定量变化的研究[J].哈尔滨医科大学学报,2014,47(4):350-352.
Zhou HB,Li JY,Zhao YH,et al.Quantitation of hepatitis B surface antigen(HBsAg)in the natural course of hepatitis B virus(HBV)infection[J].Journalof Harbin Medical University,2014,47(4):350-352.
[12] Wooddell CI,Rozema DB,Hossbach M,et al.Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection[J].Molecular Therapy,2013,21(5):973-985.
[13] 陆 伟,张占卿.血清乙型肝炎表面抗原水平预测慢性乙型肝炎病毒感染状态的研究进展[J].临床荟萃,2013,28(10):1185-1190.
Lu W,Zhang ZQ.Progress in the prediction of chronic hepatitis B virus infection by serum hepatitis B surface antigen level[J].Clinical Am Focus,2013,28(10):1185-1190.
[14] McMahon BJ.Chronic hepatitis B virus infection[J].Medical Clinics North,2014,98(1):39-54.
[15] Gane EJ,Lim YS,Gordon SC,et al.The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection[J].Journal of Hepatology,2015,63(2):320-328.
[16] 黄 允,李 艳,彭 锐,等.HBV感染致肝损伤患者CRP,hsCRP和SAA临床价值的探讨[J].现代检验医学杂志,2017,32(2):49-52.
Huang Y,Li Y,Peng R,et al.Clinical significance of SAA CRP and hsCRP in HBV hepatopathy patients[J].Journal of Modern Laboratory Medicine,2017,32(2):49-52.
相似文献/References:
[1]王 森,黄太宏,高 硕,等.系统性红斑狼疮患者乙型肝炎病毒感染的分析研究[J].现代检验医学杂志,2016,31(01):41.[doi:10.3969/j.issn.1671-7414.2016.01.011]
WANG Sen,HUANG Tai-hong,GAO Shuo,et al.Prevalence of Hepatitis B Virus Infection in Systemic
Lupus Erythematosus Patients[J].Journal of Modern Laboratory Medicine,2016,31(04):41.[doi:10.3969/j.issn.1671-7414.2016.01.011]
[2]陈雪花,雷艳君.2003~2014年安康某高校新生乙肝病毒感染及免疫接种情况调查[J].现代检验医学杂志,2017,32(01):147.[doi:10.3969/j.issn.1671-7414.2017.01.041]
CHEN Xue-hua,LEI Yan-jun.Investigation on the Freshmen' Status of the Preventive Vaccination
Against Hepatitis B in A University of Ankang City in 2003~2014[J].Journal of Modern Laboratory Medicine,2017,32(04):147.[doi:10.3969/j.issn.1671-7414.2017.01.041]
[3]李育敏,徐 怡,阚丽娟,等.荧光定量PCR测定HBV DNA测量不确定度的评定与应用探讨[J].现代检验医学杂志,2019,34(03):151.[doi:10.3969/j.issn.1671-7414.2019.03.039]
LI Yu-min,XU Yi,KAN Li-juan,et al.Investigation on the Estimation and Application of the Uncertainty ofHepatitis B Virus DNA Determination by Fluorescence Quantitative PCR[J].Journal of Modern Laboratory Medicine,2019,34(04):151.[doi:10.3969/j.issn.1671-7414.2019.03.039]
[4]吴 婕,张英杰,周华君,等.慢性HBV感染者血清持续低水平HBsAg表达免疫耐受机制的研究进展[J].现代检验医学杂志,2022,37(02):199.[doi:10.3969/j.issn.1671-7414.2022.02.040]
WU Jie,ZHANG Ying-jie,ZHOU Hua-jun,et al.doi:10.3969/j.issn.1671-7414.2022.02.040 Research Progress on Immune Tolerance Mechanism of Persistent Low-level Serum HBsAg Expression in Patients with Chronic HBV Infection[J].Journal of Modern Laboratory Medicine,2022,37(04):199.[doi:10.3969/j.issn.1671-7414.2022.02.040]